1 1602 167 MENOPAUSAL QUALITY OF LIFE: RCT OF YOGA, EXERCISE, AND OMEGA-3 SUPPLEMENTS. OBJECTIVE: THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF 3 NONHORMONAL THERAPIES FOR THE IMPROVEMENT OF MENOPAUSE-RELATED QUALITY OF LIFE IN WOMEN WITH VASOMOTOR SYMPTOMS. STUDY DESIGN: WE CONDUCTED A 12-WEEK 3 X 2 RANDOMIZED, CONTROLLED, FACTORIAL DESIGN TRIAL. PERI- AND POSTMENOPAUSAL WOMEN, 40-62 YEARS OLD, WERE ASSIGNED RANDOMLY TO YOGA (N = 107), EXERCISE (N = 106), OR USUAL ACTIVITY (N = 142) AND ALSO ASSIGNED RANDOMLY TO A DOUBLE-BLIND COMPARISON OF OMEGA-3 (N = 177) OR PLACEBO (N = 178) CAPSULES. WE PERFORMED THE FOLLOWING INTERVENTIONS: (1) WEEKLY 90-MINUTE YOGA CLASSES WITH DAILY AT-HOME PRACTICE, (2) INDIVIDUALIZED FACILITY-BASED AEROBIC EXERCISE TRAINING 3 TIMES/WEEK, AND (3) 0.615 G OMEGA-3 SUPPLEMENT, 3 TIMES/DAY. THE OUTCOMES WERE ASSESSED WITH THE FOLLOWING SCORES: MENOPAUSAL QUALITY OF LIFE QUESTIONNAIRE (MENQOL) TOTAL AND DOMAIN (VASOMOTOR SYMPTOMS, PSYCHOSOCIAL, PHYSICAL AND SEXUAL). RESULTS: AMONG 355 RANDOMLY ASSIGNED WOMEN WHO AVERAGE AGE WAS 54.7 YEARS, 338 WOMEN (95%) COMPLETED 12-WEEK ASSESSMENTS. MEAN BASELINE VASOMOTOR SYMPTOMS FREQUENCY WAS 7.6/DAY, AND THE MEAN BASELINE TOTAL MENQOL SCORE WAS 3.8 (RANGE, 1-8 FROM BETTER TO WORSE) WITH NO BETWEEN-GROUP DIFFERENCES. FOR YOGA COMPARED TO USUAL ACTIVITY, BASELINE TO 12-WEEK IMPROVEMENTS WERE SEEN FOR MENQOL TOTAL -0.3 (95% CONFIDENCE INTERVAL, -0.6 TO 0; P = .02), VASOMOTOR SYMPTOM DOMAIN (P = .02), AND SEXUALITY DOMAIN (P = .03) SCORES. FOR WOMEN WHO UNDERWENT EXERCISE AND OMEGA-3 THERAPY COMPARED WITH CONTROL SUBJECTS, IMPROVEMENTS IN BASELINE TO 12-WEEK TOTAL MENQOL SCORES WERE NOT OBSERVED. EXERCISE SHOWED BENEFIT IN THE MENQOL PHYSICAL DOMAIN SCORE AT 12 WEEKS (P = .02). CONCLUSION: ALL WOMEN BECOME MENOPAUSAL, AND MANY OF THEM SEEK MEDICAL ADVICE ON WAYS TO IMPROVE QUALITY OF LIFE; LITTLE EVIDENCE-BASED INFORMATION EXISTS. WE FOUND THAT, AMONG HEALTHY SEDENTARY MENOPAUSAL WOMEN, YOGA APPEARS TO IMPROVE MENOPAUSAL QUALITY OF LIFE; THE CLINICAL SIGNIFICANCE OF OUR FINDING IS UNCERTAIN BECAUSE OF THE MODEST EFFECT. 2014 2 1133 71 EFFICACY OF YOGA FOR VASOMOTOR SYMPTOMS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THIS STUDY AIMS TO DETERMINE THE EFFICACY OF YOGA IN ALLEVIATING VASOMOTOR SYMPTOMS (VMS) FREQUENCY AND BOTHER. METHODS: THIS STUDY WAS A THREE-BY-TWO FACTORIAL, RANDOMIZED CONTROLLED TRIAL. ELIGIBLE WOMEN WERE RANDOMIZED TO YOGA (N = 107), EXERCISE (N = 106), OR USUAL ACTIVITY (N = 142), AND WERE SIMULTANEOUSLY RANDOMIZED TO A DOUBLE-BLIND COMPARISON OF OMEGA-3 FATTY ACID (N = 177) OR PLACEBO (N = 178) CAPSULES. YOGA INTERVENTION CONSISTED OF 12 WEEKLY 90-MINUTE YOGA CLASSES WITH DAILY HOME PRACTICE. PRIMARY OUTCOMES WERE VMS FREQUENCY AND BOTHER ASSESSED BY DAILY DIARIES AT BASELINE, 6 WEEKS, AND 12 WEEKS. SECONDARY OUTCOMES INCLUDED INSOMNIA SYMPTOMS (INSOMNIA SEVERITY INDEX) AT BASELINE AND 12 WEEKS. RESULTS: AMONG 249 RANDOMIZED WOMEN, 237 (95%) COMPLETED 12-WEEK ASSESSMENTS. THE MEAN BASELINE VMS FREQUENCY WAS 7.4 PER DAY (95% CI, 6.6 TO 8.1) IN THE YOGA GROUP AND 8.0 PER DAY (95% CI, 7.3 TO 8.7) IN THE USUAL ACTIVITY GROUP. INTENT-TO-TREAT ANALYSES INCLUDED ALL PARTICIPANTS WITH RESPONSE DATA (N = 237). THERE WAS NO DIFFERENCE BETWEEN INTERVENTION GROUPS IN THE CHANGE IN VMS FREQUENCY FROM BASELINE TO 6 AND 12 WEEKS (MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 6 WK, -0.3 [95% CI, -1.1 TO 0.5]; MEAN DIFFERENCE [YOGA--USUAL ACTIVITY] FROM BASELINE AT 12 WK, -0.3 [95% CI, -1.2 TO 0.6]; P = 0.119 ACROSS BOTH TIME POINTS). RESULTS WERE SIMILAR FOR VMS BOTHER. AT WEEK 12, YOGA WAS ASSOCIATED WITH AN IMPROVEMENT IN INSOMNIA SYMPTOMS (MEAN DIFFERENCE [YOGA - USUAL ACTIVITY] IN THE CHANGE IN INSOMNIA SEVERITY INDEX, 1.3 [95% CI, -2.5 TO -0.1]; P = 0.007). CONCLUSIONS: AMONG HEALTHY WOMEN, 12 WEEKS OF YOGA CLASS PLUS HOME PRACTICE, COMPARED WITH USUAL ACTIVITY, DO NOT IMPROVE VMS FREQUENCY OR BOTHER BUT REDUCE INSOMNIA SYMPTOMS. 2014 3 2415 53 YOGA AND MEDITATION FOR MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS-A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: BREAST CANCER SURVIVORS HAVE ONLY VERY LIMITED TREATMENT OPTIONS FOR MENOPAUSAL SYMPTOMS. THE OBJECTIVE OF THIS TRIAL WAS TO EVALUATE THE EFFECTS OF A 12-WEEK TRADITIONAL HATHA YOGA AND MEDITATION INTERVENTION ON MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS. METHODS: PATIENTS WERE RANDOMLY ASSIGNED EITHER TO A 12-WEEK YOGA AND MEDITATION INTERVENTION OR TO USUAL CARE. THE PRIMARY OUTCOME MEASURE WAS TOTAL MENOPAUSAL SYMPTOMS (MENOPAUSE RATING SCALE [MRS] TOTAL SCORE). SECONDARY OUTCOME MEASURES INCLUDED MRS SUBSCALES, QUALITY OF LIFE (FUNCTIONAL ASSESSMENT OF CANCER THERAPY-BREAST), FATIGUE (FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE), DEPRESSION, AND ANXIETY (HOSPITAL ANXIETY AND DEPRESSION SCALE). OUTCOMES WERE ASSESSED AT WEEK 12 AND WEEK 24 AFTER RANDOMIZATION. RESULTS: IN TOTAL, 40 WOMEN (MEAN AGE +/- STANDARD DEVIATION, 49.2 +/- 5.9 YEARS) WERE RANDOMIZED TO YOGA (N = 19) OR TO USUAL CARE (N = 21). WOMEN IN THE YOGA GROUP REPORTED SIGNIFICANTLY LOWER TOTAL MENOPAUSAL SYMPTOMS COMPARED WITH THE USUAL CARE GROUP AT WEEK 12 (MEAN DIFFERENCE, -5.6; 95% CONFIDENCE INTERVAL, -9.2 TO -1.9; P = .004) AND AT WEEK 24 (MEAN DIFFERENCE, -4.5; 95% CONFIDENCE INTERVAL, -8.3 TO -0.7; P = .023). AT WEEK 12, THE YOGA GROUP REPORTED LESS SOMATOVEGETATIVE, PSYCHOLOGICAL, AND UROGENITAL MENOPAUSAL SYMPTOMS; LESS FATIGUE; AND IMPROVED QUALITY OF LIFE (ALL P < .05). AT WEEK 24, ALL EFFECTS PERSISTED EXCEPT FOR PSYCHOLOGICAL MENOPAUSAL SYMPTOMS. SHORT-TERM EFFECTS ON MENOPAUSAL SYMPTOMS REMAINED SIGNIFICANT WHEN ONLY WOMEN WHO WERE RECEIVING ANTIESTROGEN MEDICATION (N = 36) WERE ANALYZED. SIX MINOR ADVERSE EVENTS OCCURRED IN EACH GROUP. CONCLUSIONS: YOGA COMBINED WITH MEDITATION CAN BE CONSIDERED A SAFE AND EFFECTIVE COMPLEMENTARY INTERVENTION FOR MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS. THE EFFECTS SEEM TO PERSIST FOR AT LEAST 3 MONTHS. 2015 4 829 43 EFFECT OF YOGA ON MENOPAUSAL SYMPTOMS. OBJECTIVES: TO OBSERVE THE EFFECT OF YOGA ON MENOPAUSAL SYMPTOMS USING A PROSPECTIVE, RANDOMIZED, CONTROLLED AND INTERVENTIONAL STUDY. MAIN OUTCOME MEASURES TOTAL MENOPAUSE RATING SCALE (MRS) SCORE AND THREE SUBSCALE SCORES (SOMATOVEGETATIVE, PSYCHOLOGICAL AND UROGENITAL) WERE MEASURED ON DAY 1 AND DAY 90 IN THE STUDY GROUP WHICH PERFORMED YOGA (ASANA, PRANAYAM AND MEDITATION) UNDER SUPERVISION FOR THREE MONTHS, AND WERE COMPARED WITH THE CONTROL GROUP THAT DID NOT PERFORM YOGA. MRS HAS BEEN DESIGNED TO MEASURE HEALTH-RELATED QUALITY OF LIFE OF AGEING WOMEN. IT CONSISTS OF 11 SYMPTOMS AND THREE SUBSCALES. RESULTS: IT WAS OBSERVED THAT ON DAY 1 THE SCORES IN BOTH THE GROUPS WERE COMPARABLE. ON DAY 90, THE SCORES IN THE YOGA GROUP SHOWED A REDUCTION IN SCORE ON ALL THE SUBSCALES, WHICH WAS STATISTICALLY SIGNIFICANT. NO SIGNIFICANT DIFFERENCE WAS NOTED IN THE CONTROL GROUP. CONCLUSION: YOGA IS EFFECTIVE IN REDUCING MENOPAUSAL SYMPTOMS AND SHOULD BE CONSIDERED AS ALTERNATIVE THERAPY FOR THE MANAGEMENT OF MENOPAUSAL SYMPTOMS. 2011 5 243 48 A YOGA & EXERCISE RANDOMIZED CONTROLLED TRIAL FOR VASOMOTOR SYMPTOMS: EFFECTS ON HEART RATE VARIABILITY. OBJECTIVES: HEART RATE VARIABILITY (HRV) REFLECTS THE INTEGRATION OF THE PARASYMPATHETIC NERVOUS SYSTEM WITH THE REST OF THE BODY. STUDIES ON THE EFFECTS OF YOGA AND EXERCISE ON HRV HAVE BEEN MIXED BUT SUGGEST THAT EXERCISE INCREASES HRV. WE CONDUCTED A SECONDARY ANALYSIS OF THE EFFECT OF YOGA AND EXERCISE ON HRV BASED ON A RANDOMIZED CLINICAL TRIAL OF TREATMENTS FOR VASOMOTOR SYMPTOMS IN PERI/POST-MENOPAUSAL WOMEN. DESIGN: RANDOMIZED CLINICAL TRIAL OF BEHAVIORAL INTERVENTIONS IN WOMEN WITH VASOMOTOR SYMPTOMS (N=335), 40-62 YEARS OLD FROM THREE CLINICAL STUDY SITES. INTERVENTIONS: 12-WEEKS OF A YOGA PROGRAM, DESIGNED SPECIFICALLY FOR MID-LIFE WOMEN, OR A SUPERVISED AEROBIC EXERCISE-TRAINING PROGRAM WITH SPECIFIC INTENSITY AND ENERGY EXPENDITURE GOALS, COMPARED TO A USUAL ACTIVITY GROUP. MAIN OUTCOME MEASURES: TIME AND FREQUENCY DOMAIN HRV MEASURED AT BASELINE AND AT 12 WEEKS FOR 15MIN USING HOLTER MONITORS. RESULTS: WOMEN HAD A MEDIAN OF 7.6 VASOMOTOR SYMPTOMS PER 24H. TIME AND FREQUENCY DOMAIN HRV MEASURES DID NOT CHANGE SIGNIFICANTLY IN EITHER OF THE INTERVENTION GROUPS COMPARED TO THE CHANGE IN THE USUAL ACTIVITY GROUP. HRV RESULTS DID NOT DIFFER WHEN THE ANALYSES WERE RESTRICTED TO POST-MENOPAUSAL WOMEN. CONCLUSIONS: ALTHOUGH YOGA AND EXERCISE HAVE BEEN SHOWN TO INCREASE PARASYMPATHETIC-MEDIATED HRV IN OTHER POPULATIONS, NEITHER INTERVENTION INCREASED HRV IN MIDDLE-AGED WOMEN WITH VASOMOTOR SYMPTOMS. MIXED RESULTS IN PREVIOUS RESEARCH MAY BE DUE TO SAMPLE DIFFERENCES. YOGA AND EXERCISE LIKELY IMPROVE SHORT-TERM HEALTH IN MIDDLE-AGED WOMEN THROUGH MECHANISMS OTHER THAN HRV. 2016 6 1068 40 EFFECTS OF YOGA ON MENOPAUSAL SYMPTOMS AND SLEEP QUALITY ACROSS MENOPAUSE STATUSES: A RANDOMIZED CONTROLLED TRIAL. THIS RANDOMIZED CONTROLLED TRIAL INVESTIGATED THE EFFECTS OF YOGA ON MENOPAUSAL SYMPTOMS AND SLEEP QUALITY ACROSS MENOPAUSE STATUSES. PARTICIPANTS WERE RANDOMLY ASSIGNED TO EITHER THE INTERVENTION OR CONTROL GROUP (N = 104 EACH), AND THOSE IN THE INTERVENTION GROUP PRACTICED YOGA FOR 20 WEEKS. THE PARTICIPANTS COMPLETED THE FOLLOWING QUESTIONNAIRES: THE DEPRESSION, ANXIETY, AND STRESS SCALE; MULTIDIMENSIONAL SCALE OF PERCEIVED SOCIAL SUPPORT; MENOPAUSE RATING SCALE; AND PITTSBURGH SLEEP QUALITY INDEX. THE RESULTS REVEALED THAT YOGA EFFECTIVELY DECREASED MENOPAUSAL SYMPTOMS, WITH THE STRONGEST EFFECTS NOTED IN POSTMENOPAUSAL WOMEN (MEAN +/- STANDARD DEVIATION: 14.98 +/- 7.10), FOLLOWED BY PERIMENOPAUSAL WOMEN (6.11 +/- 2.07). YOGA SIGNIFICANTLY IMPROVED SLEEP QUALITY IN POSTMENOPAUSAL AND PERIMENOPAUSAL WOMEN AFTER CONTROLLING FOR SOCIAL SUPPORT, DEPRESSION, ANXIETY, STRESS, AND MENOPAUSAL SYMPTOMS (P < 0.001). HOWEVER, YOGA DID NOT AFFECT SLEEP QUALITY IN PREMENOPAUSAL WOMEN. OVERALL SLEEP QUALITY SIGNIFICANTLY IMPROVED IN POSTMENOPAUSAL AND PERIMENOPAUSAL WOMEN. OUR DATA INDICATE THAT YOGA CAN HELP DECREASE MENOPAUSAL SYMPTOMS, PARTICULARLY IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN, AND IMPROVE THEIR HEALTH. 2022 7 1398 47 IMPACT OF YOGA INTERVENTION ON MENOPAUSAL SYMPTOMS-SPECIFIC QUALITY OF LIFE AND CHANGES IN HORMONAL LEVEL AMONG MENOPAUSAL WOMEN. AIM: THE MENOPAUSE TRANSITION IS EXPERIENCED BY WOMEN OFTEN INVOLVES TROUBLESOME SYMPTOMS DUE TO CHANGES IN THE LEVEL OF REPRODUCTIVE HORMONES. NON-HORMONAL THERAPIES ARE MORE COMMONLY ACCEPTED BY WOMEN THAN HORMONAL THERAPY FOR COPING WITH THE CLIMACTERIC SYMPTOMS. THE AIM OF THE STUDY WAS TO EVALUATE THE EFFECTS OF YOGA PRACTICE ON MENOPAUSAL SYMPTOMS, SPECIFIC QUALITY OF LIFE, AND CHANGES IN HORMONAL LEVELS AMONG MENOPAUSAL WOMEN. METHOD: A SINGLE-BLINDED RANDOMIZED CONTROL TRIAL WAS CONDUCTED AMONG 80 PARTICIPANTS AGED 40 OF 50 YEARS AND WAS RANDOMLY DIVIDED INTO TWO STUDY ARMS, THAT IS, SUDARSHAN KRIYA YOGA (SKY) AND BRISK WALKING INTERVENTION, TO FIND THE EFFECT ON THE HORMONAL CHANGES AND MENOPAUSAL QUALITY OF LIFE (MEASURED BY MENQOL TOOL). THE SIGNIFICANT IMPROVEMENTS IN THE OUTCOME MEASURES WERE MEASURED BY USING REPEATED MEASURES ANALYSIS OF VARIANCE AND MCNEMAR'S TEST. RESULTS: SIGNIFICANT IMPROVEMENTS IN THE MENOPAUSAL-SPECIFIC QUALITY OF LIFE WERE OBSERVED IN THE DOMAIN OF VASOMOTOR, PSYCHOSOCIAL, AND PHYSICAL SYMPTOMS (P < 0.05). THE ANTIOXIDANT ENZYMES (SUPEROXIDE DISMUTASE AND GLUTATHIONE PEROXIDASE (GPX) WERE SIGNIFICANTLY ELEVATED AFTER 1 YEAR OF REGULAR PRACTICE OF SKY COMPARED TO WALKING INTERVENTION (P < 0.05). IN CONTRAST, NO SIGNIFICANT IMPROVEMENT WAS OBSERVED IN FOLLICLE-STIMULATING HORMONE AND DEHYDROEPIANDROSTERONE SULFATE LEVELS. THE WOMEN REPORTED NO ADVERSE EVENTS AFTER SKY PRACTICE OR BRISK WALKING. CONCLUSION: THE STUDY CONCLUDED THAT 1 YEAR OF SKY PRACTICE COULD BE ONE OF THE PREFERRED NON-HORMONAL, LIFESTYLE-MODIFYING REGIMENS FOR IMPROVING THE OVERALL QUALITY OF LIFE IN MENOPAUSAL WOMEN. 2021 8 2681 54 YOGA IN SEDENTARY ADULTS WITH ARTHRITIS: EFFECTS OF A RANDOMIZED CONTROLLED PRAGMATIC TRIAL. OBJECTIVE: TO EVALUATE THE EFFECT OF INTEGRAL-BASED HATHA YOGA IN SEDENTARY PEOPLE WITH ARTHRITIS. METHODS: THERE WERE 75 SEDENTARY ADULTS AGED 18+ YEARS WITH RHEUMATOID ARTHRITIS (RA) OR KNEE OSTEOARTHRITIS RANDOMLY ASSIGNED TO 8 WEEKS OF YOGA (TWO 60-MIN CLASSES AND 1 HOME PRACTICE/WK) OR WAITLIST. POSES WERE MODIFIED FOR INDIVIDUAL NEEDS. THE PRIMARY ENDPOINT WAS PHYSICAL HEALTH [MEDICAL OUTCOMES STUDY SHORT FORM-36 (SF-36) PHYSICAL COMPONENT SUMMARY (PCS)] ADJUSTED FOR BASELINE; EXPLORATORY ADJUSTED OUTCOMES INCLUDED FITNESS, MOOD, STRESS, SELF-EFFICACY, SF-36 HEALTH-RELATED QUALITY OF LIFE (HRQOL), AND RA DISEASE ACTIVITY. IN EVERYONE COMPLETING YOGA, WE EXPLORED LONGTERM EFFECTS AT 9 MONTHS. RESULTS: PARTICIPANTS WERE MOSTLY FEMALE (96%), WHITE (55%), AND COLLEGE-EDUCATED (51%), WITH A MEAN (SD) AGE OF 52 YEARS (12 YRS). AVERAGE DISEASE DURATION WAS 9 YEARS AND 49% HAD RA. AT 8 WEEKS, YOGA WAS ASSOCIATED WITH SIGNIFICANTLY HIGHER PCS (6.5, 95% CI 2.0-10.7), WALKING CAPACITY (125 M, 95% CI 15-235), POSITIVE AFFECT (5.2, 95% CI 1.4-8.9), AND LOWER CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE (-3.0, 95% CI -4.8 - -1.3). SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE EVIDENT IN SF-36 ROLE PHYSICAL, PAIN, GENERAL HEALTH, VITALITY, AND MENTAL HEALTH SCALES. BALANCE, GRIP STRENGTH, AND FLEXIBILITY WERE SIMILAR BETWEEN GROUPS. TWENTY-TWO OUT OF 28 IN THE WAITLIST GROUP COMPLETED YOGA. AMONG ALL YOGA PARTICIPANTS, SIGNIFICANT (P < 0.05) IMPROVEMENTS WERE OBSERVED IN MEAN PCS, FLEXIBILITY, 6-MIN WALK, AND ALL PSYCHOLOGICAL AND MOST HRQOL DOMAINS AT 8 WEEKS WITH MOST STILL EVIDENT 9 MONTHS LATER. OF 7 ADVERSE EVENTS, NONE WERE ASSOCIATED WITH YOGA. CONCLUSION: PRELIMINARY EVIDENCE SUGGESTS YOGA MAY HELP SEDENTARY INDIVIDUALS WITH ARTHRITIS SAFELY INCREASE PHYSICAL ACTIVITY, AND IMPROVE PHYSICAL AND PSYCHOLOGICAL HEALTH AND HRQOL. CLINICAL TRIALS NCT00349869. 2015 9 2521 50 YOGA DECREASES INSOMNIA IN POSTMENOPAUSAL WOMEN: A RANDOMIZED CLINICAL TRIAL. OBJECTIVE: THE PRACTICE OF YOGA HAS BEEN PROVEN TO HAVE POSITIVE EFFECTS ON REDUCING INSOMNIA. STUDIES HAVE ALSO SHOWN ITS EFFECTS ON REDUCING CLIMACTERIC SYMPTOMS. TO DATE, HOWEVER, NO STUDIES THAT EVALUATE THE EFFECTS OF YOGA ON POSTMENOPAUSAL WOMEN WITH A DIAGNOSIS OF INSOMNIA IN A RANDOMIZED CLINICAL TRIAL HAVE BEEN CONDUCTED. THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECT OF YOGA PRACTICE ON THE PHYSICAL AND MENTAL HEALTH AND CLIMACTERIC SYMPTOMS OF POSTMENOPAUSAL WOMEN WITH A DIAGNOSIS OF INSOMNIA. METHODS: POSTMENOPAUSAL WOMEN NOT UNDERGOING HORMONE THERAPY, WHO WERE 50 TO 65 YEARS OLD, WHO HAD AN APNEA-HYPOPNEA INDEX LESS THAN 15, AND WHO HAD A DIAGNOSIS OF INSOMNIA WERE RANDOMLY ASSIGNED TO ONE OF THREE GROUPS, AS FOLLOWS: CONTROL, PASSIVE STRETCHING, AND YOGA. QUESTIONNAIRES WERE ADMINISTERED BEFORE AND 4 MONTHS AFTER THE INTERVENTION TO EVALUATE QUALITY OF LIFE, ANXIETY AND DEPRESSION SYMPTOMS, CLIMACTERIC SYMPTOMS, INSOMNIA SEVERITY, DAYTIME SLEEPINESS, AND STRESS. THE VOLUNTEERS ALSO UNDERWENT POLYSOMNOGRAPHY. THE STUDY LASTED 4 MONTHS. RESULTS: THERE WERE 44 VOLUNTEERS AT THE END OF THE STUDY. WHEN COMPARED WITH THE CONTROL GROUP, THE YOGA GROUP HAD SIGNIFICANTLY LOWER POSTTREATMENT SCORES FOR CLIMACTERIC SYMPTOMS AND INSOMNIA SEVERITY AND HIGHER SCORES FOR QUALITY OF LIFE AND RESISTANCE PHASE OF STRESS. THE REDUCTION IN INSOMNIA SEVERITY IN THE YOGA GROUP WAS SIGNIFICANTLY HIGHER THAN THAT IN THE CONTROL AND PASSIVE-STRETCHING GROUPS. CONCLUSIONS: THIS STUDY SHOWED THAT A SPECIFIC SEQUENCE OF YOGA MIGHT BE EFFECTIVE IN REDUCING INSOMNIA AND MENOPAUSAL SYMPTOMS AS WELL AS IMPROVING QUALITY OF LIFE IN POSTMENOPAUSAL WOMEN WITH INSOMNIA. 2012 10 428 41 CAN YOGA HAVE ANY EFFECT ON SHOULDER AND ARM PAIN AND QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER? A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF YOGA ON SHOULDER AND ARM PAIN, QUALITY OF LIFE (QOL), DEPRESSION, AND PHYSICAL PERFORMANCE IN PATIENTS WITH BREAST CANCER. METHODS: THIS PROSPECTIVE, RANDOMIZED STUDY INCLUDED 42 PATIENTS. THE PATIENTS IN GROUP 1 UNDERWENT A 10-WEEK HATHA YOGA EXERCISE PROGRAM. THE PATIENTS IN GROUP 2 WERE INCLUDED IN A 10-WEEK FOLLOW-UP PROGRAM. OUR PRIMARY ENDPOINT WAS ARM AND SHOULDER PAIN INTENSITY. RESULTS: THE GROUP RECEIVING YOGA SHOWED A SIGNIFICANT IMPROVEMENT IN THEIR PAIN SEVERITY FROM BASELINE TO POST-TREATMENT, AND THESE BENEFITS WERE MAINTAINED AT 2.5 MONTHS POST-TREATMENT. WHEN COMPARED TO THE CONTROL GROUP, THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE 2 GROUPS WITH RESPECT TO THE PARAMETERS ASSESSED AT THE END OF WEEK 10. CONCLUSION: YOGA WAS AN EFFECTIVE AND SAFE EXERCISE FOR ALLEVIATING SHOULDER AND ARM PAIN, WHICH IS A COMPLICATION WITH A HIGH PREVALENCE IN PATIENTS WITH BREAST CANCER. 2018 11 1859 50 RANDOMIZED CONTROLLED PILOT TRIAL OF YOGA IN OVERWEIGHT AND OBESE BREAST CANCER SURVIVORS: EFFECTS ON QUALITY OF LIFE AND ANTHROPOMETRIC MEASURES. PURPOSE: TO OBTAIN ESTIMATES OF TIME TO RECRUIT THE STUDY SAMPLE, RETENTION, FACILITY-BASED CLASS ATTENDANCE AND HOME PRACTICE FOR A STUDY OF YOGA IN BREAST CANCER SURVIVORS, AND ITS EFFICACY ON FATIGUE, QUALITY OF LIFE (QOL), AND WEIGHT CHANGE. METHODS: SIXTY-THREE POST-TREATMENT STAGES 0-III BORDERLINE OVERWEIGHT AND OBESE (BODY MASS INDEX >/= 24 KG/M(2)) BREAST CANCER SURVIVORS WERE RANDOMLY ASSIGNED TO A 6-MONTH, FACILITY- AND HOME-BASED VINIYOGA INTERVENTION (N = 32) OR A WAITLIST CONTROL GROUP (N = 31). THE YOGA GOAL WAS FIVE PRACTICES PER WEEK. PRIMARY OUTCOME MEASURES WERE CHANGES IN QOL, FATIGUE, AND WEIGHT FROM BASELINE TO 6 MONTHS. SECONDARY OUTCOMES INCLUDED CHANGES IN WAIST AND HIP CIRCUMFERENCE. RESULTS: IT TOOK 12 MONTHS TO COMPLETE RECRUITMENT. PARTICIPANTS ATTENDED A MEAN OF 19.6 CLASSES AND PRACTICED AT HOME A MEAN OF 55.8 TIMES DURING THE 6-MONTH PERIOD. AT FOLLOW-UP, 90% OF PARTICIPANTS COMPLETED QUESTIONNAIRES AND 87% COMPLETED ANTHROPOMETRIC MEASUREMENTS. QOL AND FATIGUE IMPROVED TO A GREATER EXTENT AMONG WOMEN IN THE YOGA GROUP RELATIVE TO WOMEN IN THE CONTROL GROUP, ALTHOUGH NO DIFFERENCES WERE STATISTICALLY SIGNIFICANT. WAIST CIRCUMFERENCE DECREASED 3.1 CM (95% CI, -5.7 AND -0.4) MORE AMONG WOMEN IN THE YOGA COMPARED WITH THE CONTROL GROUP, WITH NO DIFFERENCE IN WEIGHT CHANGE. CONCLUSIONS: THIS STUDY PROVIDES IMPORTANT INFORMATION REGARDING RECRUITMENT, RETENTION, AND PRACTICE LEVELS ACHIEVED DURING A 6-MONTH, INTENSIVE YOGA INTERVENTION IN OVERWEIGHT AND OBESE BREAST CANCER SURVIVORS. YOGA MAY HELP DECREASE WAIST CIRCUMFERENCE AND IMPROVE QUALITY OF LIFE; FUTURE STUDIES ARE NEEDED TO CONFIRM THESE RESULTS. 2012 12 764 43 EFFECT OF THE INFORMATION SUPPORT METHOD COMBINED WITH YOGA EXERCISE ON THE DEPRESSION, ANXIETY, AND SLEEP QUALITY OF MENOPAUSAL WOMEN. BACKGROUND: MENOPAUSE IS A SPECIAL STAGE IN A WOMAN'S LIFE, BUT NO SAFE CLINICAL TREATMENT EXISTS AGAINST MENOPAUSAL SYMPTOMS. TO ANALYZE THE EFFECT OF THE INFORMATION SUPPORT METHOD COMBINED WITH YOGA EXERCISE ON THE DEPRESSION, ANXIETY, AND SLEEP QUALITY OF MENOPAUSAL WOMEN. SUBJECTS AND METHODS: FROM JUNE 2019 TO DECEMBER 2019, MENOPAUSAL WOMEN WHO WERE NEWLY RECRUITED IN THREE YOGA CLUBS IN THREE CITIES IN EAST CHINA WERE SELECTED AS THE PARTICIPANTS BY CONVENIENCE SAMPLING. A TOTAL OF 52 WOMEN WERE IN THE EXPERIMENT GROUP AND 54 WERE IN THE CONTROL GROUP. IN 24 WEEKS, THE EXPERIMENT GROUP ENGAGED IN YOGA EXERCISE FOR 60 MINUTES EACH TIME, THREE TIMES A WEEK. THEY GROUP WAS GIVEN PROFESSIONAL POSITIVE PSYCHOLOGICAL INFORMATION SUPPORT AT THE SAME TIME. THE KUPPERMAN MENOPAUSAL SYMPTOM DISTRESS SCALE, SELF-RATING DEPRESSION SCALE (SDS), SELF-RATING ANXIETY SCALE (SAS), AND PITTSBURGH SLEEP QUALITY INDEX (PSQI) WERE USED BEFORE THE EXPERIMENT, THREE MONTHS INTO THE EXPERIMENT, AND SIX MONTHS INTO THE EXPERIMENT TO MONITOR THE INTERVENTION EFFECT ON THE PARTICIPANTS. RESULTS: AFTER THE INTERVENTION, THE SYMPTOMS OF DISTRESS AMONG MENOPAUSAL WOMEN IN THE EXPERIMENT GROUP AND THE KUPPERMAN SCORE OF THE EXPERIMENT GROUP REDUCED SIGNIFICANTLY. REPEATED MEASURES OF ANALYSIS OF VARIANCE WERE CONDUCTED IN THE TWO GROUPS (P<0.001). AFTER THE INTERVENTION, THE DEPRESSION SCORE OF THE EXPERIMENT GROUP DECREASED SIGNIFICANTLY. A SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN THE TWO GROUPS IN REPEATED MEASURES ANALYSIS OF VARIANCE IN THE SDS SCORE (P<0.001). AFTER THE INTERVENTION, THE ANXIETY SCORE OF THE EXPERIMENT GROUP REDUCED SIGNIFICANTLY, AND REPEATED MEASURES OF ANALYSIS OF VARIANCE IN THE SAS SCORE WERE CONDUCTED IN THE TWO GROUPS (P<0.001). AFTER THE INTERVENTION, THE SLEEP QUALITY OF THE EXPERIMENT GROUP IMPROVED, AND REPEATED MEASURES OF ANALYSIS OF VARIANCE IN SLEEP QUALITY WERE CONDUCTED IN THE TWO GROUPS (P<0.001). CONCLUSIONS: THE INFORMATION SUPPORT METHOD COMBINED WITH YOGA EXERCISE CAN ALLEVIATE THE DEPRESSION AND ANXIETY OF MENOPAUSAL WOMEN, IMPROVE THEIR SLEEP QUALITY, AND REDUCE THEIR SYMPTOMS OF MENOPAUSAL DISTRESS. 2020 13 2811 43 YOGA TO PREVENT MOBILITY LIMITATIONS IN OLDER ADULTS: FEASIBILITY OF A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE LOSS OF MOBILITY DURING AGING IMPACTS INDEPENDENCE AND LEADS TO FURTHER DISABILITY, MORBIDITY, AND REDUCED LIFE EXPECTANCY. OUR OBJECTIVE WAS TO EXAMINE THE FEASIBILITY AND SAFETY OF CONDUCTING A RANDOMIZED CONTROLLED TRIAL OF YOGA FOR OLDER ADULTS AT RISK FOR MOBILITY LIMITATIONS. METHODS: SEDENTARY OLDER ADULTS (N = 46; AGE 60-89) WERE RECRUITED AND RANDOMIZED TO EITHER YOGA OR A HEALTH EDUCATION COMPARISON GROUP. YOGA SESSIONS (60-MIN) OCCURRED 2X WEEKLY, AND 90-MIN HEALTH EDUCATION SESSIONS OCCURRED WEEKLY, FOR 10 WEEKS. THE PRIMARY OUTCOMES WERE RECRUITMENT RATE, INTERVENTION ATTENDANCE, AND RETENTION AT ASSESSMENTS. ADVERSE EVENT RATES AND PARTICIPANT SATISFACTION WERE ALSO MEASURED. PHYSICAL PERFORMANCE MEASURES OF GAIT, BALANCE, AND STRENGTH AND SELF-REPORT OUTCOME MEASURES WERE ADMINISTERED AT BASELINE AND 10-WEEKS. RESULTS: RECRUITMENT LASTED 6 MONTHS. RETENTION OF PARTICIPANTS AT THE 10-WEEK FOLLOW-UP WAS HIGH (89% - PERFORMANCE MEASURES; 98% - SELF-REPORT QUESTIONNAIRES). ATTENDANCE WAS GOOD WITH 82% OF YOGA AND 74% OF HEALTH EDUCATION PARTICIPANTS ATTENDING AT LEAST 50% OF THE SESSIONS. NO SERIOUS ADVERSE EVENTS WERE REPORTED. PATIENT SATISFACTION WITH THE INTERVENTIONS WAS HIGH. THE MEAN EFFECT SIZE FOR THE PHYSICAL PERFORMANCE MEASURES WAS 0.35 WITH SOME OVER 0.50. THE MEAN EFFECT SIZE FOR SELF-REPORT OUTCOME MEASURES WAS 0.36. CONCLUSIONS: RESULTS INDICATE THAT IT IS FEASIBLE TO CONDUCT A LARGER RCT OF YOGA FOR SEDENTARY OLDER ADULTS AT RISK FOR MOBILITY PROBLEMS. THE YOGA AND COMPARISON INTERVENTIONS WERE SAFE, WELL ACCEPTED, AND WELL ATTENDED. EFFECT SIZES SUGGEST YOGA MAY HAVE IMPORTANT BENEFITS FOR THIS POPULATION AND SHOULD BE STUDIED FURTHER. TRIAL REGISTRATION: CLINICALTRIALS # NCT03544879 ; RETROSPECTIVELY REGISTERED 4 JUNE, 2018. 2018 14 2644 40 YOGA FOR WOMEN WITH URGENCY URINARY INCONTINENCE: A PILOT STUDY. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE FEASIBILITY OF A GENTLE YOGA PROGRAM FOR WOMEN WITH URGENCY URINARY INCONTINENCE (UUI). ALSO, THESE PRELIMINARY DATA CAN EVALUATE IF YOGA IMPROVES SYMPTOM BURDEN, QUALITY OF LIFE, AND INFLAMMATORY BIOMARKERS FOR WOMEN WITH UUI. METHODS: THIS PROSPECTIVE NONRANDOMIZED SINGLE-ARM PILOT STUDY EVALUATED THE EFFECTIVENESS OF A TWICE-WEEKLY, 8-WEEK GENTLE YOGA INTERVENTION TO REDUCE UUI SYMPTOM BURDEN. CHANGES IN SYMPTOM BURDEN WERE MEASURED USING THE PELVIC FLOOR DISTRESS INVENTORY 20. SECONDARY MEASURES INCLUDED QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, SLEEP, STRESS, ANXIETY, AND INFLAMMATORY BIOMARKERS. OUTCOMES WERE EVALUATED WITH PAIRED T TESTING. RESULTS: TWELVE WOMEN COMPLETED THE YOGA INTERVENTION WITH NO ADVERSE OUTCOMES NOTED. URGENCY SYMPTOM BURDEN WAS SIGNIFICANTLY IMPROVED AFTER THE INTERVENTION (P = 0.01), AND WOMEN REPORTED AN INCREASE IN QUALITY OF LIFE (P = 0.04) AFTER THE YOGA INTERVENTION. FOLLOWING THE YOGA INTERVENTION, THE MAJORITY OF WOMEN REPORTED SYMPTOMS AS "MUCH BETTER" (N = 4 [33%]) AND "A LITTLE BETTER" (N = 5 [42%]), WITH 3 WOMEN (25%) REPORTING "NO CHANGE." WOMEN ALSO REPORTED SIGNIFICANT REDUCTION IN DEPRESSIVE SYMPTOMS (P = 0.03) AND BETTER QUALITY OF SLEEP (P = 0.03). NO SIGNIFICANT CHANGES WERE FOUND IN ANXIETY OR STRESS PERCEPTION. PLASMA LEVELS OF THE INFLAMMATORY BIOMARKER TUMOR NECROSIS FACTOR ALPHA WERE REDUCED AFTER YOGA INTERVENTION (P = 0.009); HOWEVER, NO SIGNIFICANT POSTYOGA CHANGES WERE FOUND FOR INTERLEUKIN 6 OR C-REACTIVE PROTEIN. CONCLUSIONS: THIS STUDY PROVIDES PRELIMINARY EVIDENCE THAT YOGA IS A FEASIBLE COMPLEMENTARY THERAPY THAT REDUCES INCONTINENCE SYMPTOM BURDEN, ALONG WITH IMPROVING QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, AND SLEEP QUALITY. ADDITIONALLY, YOGA MAY LOWER INFLAMMATORY BIOMARKERS ASSOCIATED WITH INCONTINENCE. 2021 15 1731 46 PERSONALIZED YOGA THERAPY FOR MULTIPLE SCLEROSIS: EFFECT ON SYMPTOM MANAGEMENT AND QUALITY OF LIFE. THIS STUDY AIMED TO ASSESS THE FEASIBILITY OF PERSONALIZED YOGA THERAPY INTERVENTION IN A PRIVATE SETTING AND ITS EFFECT ON QUALITY OF LIFE (QOL), SLEEP QUALITY, AND SYMPTOM RELIEF AMONG PATIENTS WITH MULTIPLE SCLEROSIS (MS). A SINGLE-GROUP PRE- AND POST-EXPERIMENTAL STUDY WAS CONDUCTED AMONG 10 MEMBERS OF THE MULTIPLE SCLEROSIS SOCIETY OF INDIA BETWEEN DECEMBER 2017 AND APRIL 2018. AT BASELINE AND DURING FOLLOW-UP, QOL, SLEEP QUALITY, SYMPTOMS, AND PAIN WERE ASSESSED USING THE MULTIPLE SCLEROSIS QUALITY OF LIFE, PITTSBURGH SLEEP QUALITY INDEX, MS SYMPTOM CHECKLIST, AND VISUAL ANALOGUE SCALE, RESPECTIVELY. THE INTERVENTION COMPRISED 12 PRIVATE CUSTOMIZED YOGA SESSIONS OF 1 HOUR DURATION AND THREE GROUP SESSIONS, ALL SPREAD OVER 3-MONTHS. PATIENT FEEDBACK AND DIRECT OBSERVATIONS BY THE YOGA THERAPIST WE RE DOCUMENTED AT EACH SESSION. TEN PATIENTS (SEVEN FEMALE, THREE MALE, AGE 31-52 YEARS) WERE ENROLLED IN THE YOGA INTERVENTION; SEVEN COMPLETED 8-12 SESSIONS, AND THREE COMPLETED FEWER THAN 5 SESSIONS. THERAPIST-TO-PATIENT RATIO WAS 1:2. ALL DOMAINS EXCEPT SEXUAL FUNCTION SHOWED CLINICALLY SIGNIFICANT IMPROVEMENT IN QOL SCORES. STATISTICALLY SIGNIFICANT IMPROVEMENT WAS FOUND IN SOCIAL FUNCTION (P = 0.014) AND CHANGE IN HEALTH STATUS (P = 0.029) SCORES AFTER THE INTERVENTION. ALTHOUGH THERE WAS IMPROVEMENT IN PAIN AND SLEEP QUALITY, THESE CHANGES WERE NOT STATISTICALLY SIGNIFICANT. PATIENTS REPORTED IMPROVEMENT IN SYMPTOMS WITH PRACTICE OF YOGA ALONGSIDE LIFESTYLE CHANGES. THE STUDY SUPPORTS THE FEASIBILITY OF THIS 3-MONTH YOGA INTERVENTION FOR PATIENTS WITH MS. STUDIES WITH LARGER SAMPLE SIZES ARE REQUIRED TO CONFIRM OUR FINDINGS. 2021 16 2230 39 THE IMPACT OF YOGA ON FATIGUE IN CANCER SURVIVORSHIP: A META-ANALYSIS. BACKGROUND: MIND-BODY APPROACHES, PARTICULARLY YOGA, ARE USED BY CANCER SURVIVORS TO COPE WITH TREATMENT-RELATED SYMPTOMS. CONSISTENCY OF YOGA-RELATED EFFECTS ON TREATMENT-RELATED SYMPTOMS ARE NOT KNOWN. THIS META-ANALYSIS WAS DESIGNED TO EXAMINE EFFECTS OF YOGA ON PRE- TO POSTINTERVENTION IMPROVEMENTS IN FATIGUE AMONG CANCER PATIENTS. METHODS: PUBMED AND PSYCINFO WERE SEARCHED FOR PEER-REVIEWED ARTICLES OF YOGA RANDOMIZED CONTROLLED TRIALS INCLUDING CANCER SURVIVORS AND REPORTING AT LEAST ONE FATIGUE MEASURE. TWENTY-NINE STUDIES MET INCLUSION CRITERIA (N = 1828 PATIENTS). EFFECT SIZES (HEDGE'S G) WERE CALCULATED FOR FATIGUE, DEPRESSION, AND QUALITY OF LIFE. PATIENT-RELATED AND INTERVENTION-RELATED CHARACTERISTICS WERE TESTED AS MODERATORS OF OUTCOMES. ALL STATISTICAL TESTS WERE TWO-SIDED. RESULTS: YOGA PRACTICE WAS ASSOCIATED WITH A SMALL, STATISTICALLY SIGNIFICANT DECREASE IN FATIGUE (G = 0.45, P = .013). YOGA TYPE WAS A STATISTICALLY SIGNIFICANT MODERATOR OF THIS RELATIONSHIP (P = .02). YOGA WAS ASSOCIATED WITH A MODERATE DECREASE IN DEPRESSION (G = 0.72, P = .007) BUT WAS NOT ASSOCIATED WITH STATISTICALLY SIGNIFICANT CHANGES IN QUALITY OF LIFE (P = .48). SESSION LENGTH WAS A STATISTICALLY SIGNIFICANT MODERATOR OF THE RELATIONSHIP BETWEEN YOGA AND DEPRESSION (P = .004). NEITHER TIMING OF TREATMENT (DURING TREATMENT VS POSTTREATMENT) NOR CLINICAL CHARACTERISTICS WERE STATISTICALLY SIGNIFICANT MODERATORS OF THE EFFECTS OF YOGA ON OUTCOMES. THE EFFECT OF YOGA ON FATIGUE AND DEPRESSION WAS LARGER WHEN THE COMPARATOR WAS A "WAITLIST" OR "USUAL CARE" THAN WHEN THE CONTROL GROUP WAS ANOTHER ACTIVE TREATMENT (P = .036). CONCLUSIONS: RESULTS SUGGEST YOGA MAY BE BENEFICIAL AS A COMPONENT OF TREATMENT FOR BOTH FATIGUE AND DEPRESSION IN CANCER SURVIVORS. 2020 17 640 38 DO YOGA AND AEROBIC EXERCISE TRAINING HAVE IMPACT ON FUNCTIONAL CAPACITY, FATIGUE, PERIPHERAL MUSCLE STRENGTH, AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS? AIM: THE AIM OF THE STUDY WAS TO COMPARE THE EFFECTS OF AEROBIC EXERCISE TRAINING AND YOGA ON THE FUNCTIONAL CAPACITY, PERIPHERAL MUSCLE STRENGTH, QUALITY OF LIFE (QOL), AND FATIGUE IN BREAST CANCER SURVIVORS. MATERIAL AND METHODS: A TOTAL OF 52 PATIENTS WITH A DIAGNOSIS OF BREAST CANCER WERE INCLUDED IN THE STUDY. THE PATIENTS WERE RANDOMLY ASSIGNED TO 2 GROUPS: AEROBIC EXERCISE (N = 28) AND YOGA ADDED TO AEROBIC EXERCISE (N = 24). BOTH GROUPS PARTICIPATED IN SUBMAXIMAL EXERCISE 30 MINUTES/D, 3 D/WK FOR 6 WEEKS. THE SECOND GROUP PARTICIPATED IN A 1-HOUR YOGA PROGRAM IN ADDITION TO AEROBIC EXERCISE TRAINING. FUNCTIONAL CAPACITY WAS ASSESSED BY THE 6-MINUTE WALK TEST (6MWT). PERIPHERAL MUSCLE STRENGTH WAS EVALUATED WITH A HAND-HELD DYNAMOMETER. THE FATIGUE SEVERITY LEVEL WAS ASSESSED WITH THE FATIGUE SEVERITY SCALE (FSS). THE QOL WAS DETERMINED BY THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE. RESULTS: THERE WERE STATISTICALLY SIGNIFICANT INCREASES IN PERIPHERAL MUSCLE STRENGTH, THE 6MWT DISTANCE, AND THE PERCEPTION OF QOL IN BOTH GROUPS (P < .05). ADDITIONALLY, THE GROUP WITH AEROBIC EXERCISE AND YOGA SHOWED MARKED IMPROVEMENT COMPARED WITH THE AEROBIC EXERCISE GROUP IN FATIGUE PERCEPTION (P < .05). CONCLUSION: ACCORDING TO THE DATA FROM THIS STUDY, AEROBIC EXERCISE TRAINING AND YOGA IMPROVED THE FUNCTIONAL CAPACITY AND QOL OF BREAST CANCER PATIENTS. AEROBIC EXERCISE PROGRAMS CAN BE SUPPORTED BY BODY MIND TECHNIQUES, SUCH AS YOGA, IN THE REHABILITATION OF CANCER PATIENTS FOR IMPROVING FUNCTIONAL RECOVERY AND PSYCHOSOCIAL WELLNESS. 2015 18 2667 41 YOGA IN HEART FAILURE PATIENTS: A PILOT STUDY. BACKGROUND: COMPLEMENTARY THERAPIES SUCH AS YOGA PRACTICE HAVE BECOME COMMONPLACE, YET THE SAFETY, PHYSICAL, AND PSYCHOLOGICAL EFFECTS ON PATIENTS WITH HEART FAILURE (HF) ARE UNKNOWN. THE PURPOSE OF THIS STUDY WAS TO DETERMINE WHETHER AN 8-WEEK YOGA PROGRAM WAS SAFE AND WOULD POSITIVELY INFLUENCE PHYSICAL AND PSYCHOLOGICAL FUNCTION IN HF PATIENTS. METHODS AND RESULTS: STABLE HF PATIENTS WERE RECRUITED (N = 15) AND COMPLETED (N = 12) 8 WEEKS OF YOGA CLASSES. DATA COLLECTED WERE: SAFETY (CARDIAC AND ORTHOPEDIC ADVERSE EVENTS); PHYSICAL FUNCTION (STRENGTH, BALANCE, ENDURANCE, FLEXIBILITY); AND PSYCHOLOGICAL FUNCTION (QUALITY OF LIFE [QOL], DEPRESSION SCORES, MINDFULNESS) BEFORE AND AFTER 8 WEEKS OF YOGA CLASSES. RESULTS: MEAN AGE WAS 52.4 + OR - 11.6 WITH THREE-FOURTHS (N = 9) BEING MALE AND CAUCASIAN. NO PARTICIPANT HAD ANY ADVERSE EVENTS. ENDURANCE (P < .02) AND STRENGTH (UPPER P = .04 AND LOWER BODY P = .01) SIGNIFICANTLY IMPROVED. BALANCE IMPROVED BY 13.6 SECONDS (26.9 + OR - 19.7 TO 40.0 + OR - 18.5; P = .05). SYMPTOM STABILITY, A SUBSCALE OF QOL, IMPROVED SIGNIFICANTLY (P = .02). ALTHOUGH NO SUBJECT WAS DEPRESSED, OVERALL MOOD WAS IMPROVED. SUBJECTS SUBJECTIVELY REPORTED IMPROVEMENTS IN OVERALL WELL-BEING. CONCLUSIONS: YOGA PRACTICE WAS SAFE, WITH PARTICIPANTS EXPERIENCING IMPROVED PHYSICAL FUNCTION AND SYMPTOM STABILITY. LARGER STUDIES ARE WARRANTED TO PROVIDE MORE NONPHARMACOLOGICAL OPTIONS FOR IMPROVED OUTCOMES IN PATIENTS WITH HF. 2010 19 1902 45 RESTORATIVE YOGA IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED, CONTROLLED PILOT TRIAL. BACKGROUND: METABOLIC SYNDROME INCREASES THE RISK OF DIABETES AND CARDIOVASCULAR DISEASE. YOGA IMPROVES SOME METABOLIC PARAMETERS, BUT IT HAS NOT BEEN STUDIED IN PERSONS WITH METABOLIC SYNDROME. WE CONDUCTED A RANDOMIZED CONTROLLED PILOT TRIAL TO DETERMINE WHETHER A RESTORATIVE YOGA INTERVENTION WAS FEASIBLE AND ACCEPTABLE IN UNDERACTIVE, OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. METHODS: TWENTY SIX UNDERACTIVE, OVERWEIGHT ADULT MEN AND WOMEN WITH METABOLIC SYNDROME WERE RANDOMIZED TO ATTEND 15 YOGA SESSIONS OF 90 MINUTES EACH OVER 10 WEEKS OR TO A WAIT-LIST CONTROL GROUP. FEASIBILITY WAS MEASURED BY RECRUITMENT RATES, SUBJECT RETENTION, AND ADHERENCE. ACCEPTABILITY WAS ASSESSED BY INTERVIEW AND QUESTIONNAIRES. CHANGES IN METABOLIC OUTCOMES AND QUESTIONNAIRE MEASURES FROM BASELINE TO WEEK 10 WERE CALCULATED. RESULTS: A TOTAL OF 280 PEOPLE WERE SCREENED BY PHONE, AND 93 WITH HIGH LIKELIHOOD OF METABOLIC SYNDROME WERE INVITED TO A SCREENING VISIT. OF THE 68 WHO ATTENDED SCREENING VISITS, 26 (38%) WERE RANDOMIZED, AND 24 (92%) COMPLETED THE TRIAL. ATTENDANCE AT YOGA CLASSES AND ADHERENCE TO HOME PRACTICE EXCEEDED OUR GOALS. IN THE YOGA GROUP, ALL PARTICIPANTS GAVE THE STUDY THE HIGHEST POSSIBLE SATISFACTION RATING, AND THE MAJORITY (87%) FELT THAT THE YOGA POSES WERE EASY TO PERFORM. THERE WAS TREND TO REDUCED BLOOD PRESSURE (P = 0.07), A SIGNIFICANT INCREASE IN ENERGY LEVEL (P < 0.009), AND TRENDS TO IMPROVEMENT IN WELL-BEING (P < 0.12) AND STRESS (P < 0.22) IN THE YOGA VERSUS CONTROL GROUP. CONCLUSIONS: RESTORATIVE YOGA WAS A FEASIBLE AND ACCEPTABLE INTERVENTION IN OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. THE EFFICACY OF YOGA FOR IMPROVING METABOLIC PARAMETERS IN THIS POPULATION SHOULD BE EXPLORED IN A LARGER RANDOMIZED CONTROLLED TRIAL. 2008 20 1180 44 EVALUATION OF THE EFFECTIVENESS AND EFFICACY OF IYENGAR YOGA THERAPY ON CHRONIC LOW BACK PAIN. STUDY DESIGN: THE EFFECTIVENESS AND EFFICACY OF IYENGAR YOGA FOR CHRONIC LOW BACK PAIN (CLBP) WERE ASSESSED WITH INTENTION-TO-TREAT AND PER-PROTOCOL ANALYSIS. NINETY SUBJECTS WERE RANDOMIZED TO A YOGA (N = 43) OR CONTROL GROUP (N = 47) RECEIVING STANDARD MEDICAL CARE. PARTICIPANTS WERE FOLLOWED 6 MONTHS AFTER COMPLETION OF THE INTERVENTION. OBJECTIVE: THIS STUDY AIMED TO EVALUATE IYENGAR YOGA THERAPY ON CHRONIC LOW BACK PAIN. YOGA SUBJECTS WERE HYPOTHESIZED TO REPORT GREATER REDUCTIONS IN FUNCTIONAL DISABILITY, PAIN INTENSITY, DEPRESSION, AND PAIN MEDICATION USAGE THAN CONTROLS. SUMMARY OF BACKGROUND DATA: CLBP IS A MUSCULOSKELETAL DISORDER WITH PUBLIC HEALTH AND ECONOMIC IMPACT. PILOT STUDIES OF YOGA AND BACK PAIN HAVE REPORTED SIGNIFICANT CHANGES IN CLINICALLY IMPORTANT OUTCOMES. METHODS: SUBJECTS WERE RECRUITED THROUGH SELF-REFERRAL AND HEALTH PROFESSIONAL REFERRALS ACCORDING TO EXPLICIT INCLUSION/EXCLUSION CRITERIA. YOGA SUBJECTS PARTICIPATED IN 24 WEEKS OF BIWEEKLY YOGA CLASSES DESIGNED FOR CLBP. OUTCOMES WERE ASSESSED AT 12 (MIDWAY), 24 (IMMEDIATELY AFTER), AND 48 WEEKS (6-MONTH FOLLOW-UP) AFTER THE START OF THE INTERVENTION USING THE OSWESTRY DISABILITY QUESTIONNAIRE, A VISUAL ANALOG SCALE, THE BECK DEPRESSION INVENTORY, AND A PAIN MEDICATION-USAGE QUESTIONNAIRE. RESULTS: USING INTENTION-TO-TREAT ANALYSIS WITH REPEATED MEASURES ANOVA (GROUP X TIME), SIGNIFICANTLY GREATER REDUCTIONS IN FUNCTIONAL DISABILITY AND PAIN INTENSITY WERE OBSERVED IN THE YOGA GROUP WHEN COMPARED TO THE CONTROL GROUP AT 24 WEEKS. A SIGNIFICANTLY GREATER PROPORTION OF YOGA SUBJECTS ALSO REPORTED CLINICAL IMPROVEMENTS AT BOTH 12 AND 24 WEEKS. IN ADDITION, DEPRESSION WAS SIGNIFICANTLY LOWER IN YOGA SUBJECTS. FURTHERMORE, WHILE A REDUCTION IN PAIN MEDICATION OCCURRED, THIS WAS COMPARABLE IN BOTH GROUPS. WHEN RESULTS WERE ANALYZED USING PER-PROTOCOL ANALYSIS, IMPROVEMENTS WERE OBSERVED FOR ALL OUTCOMES IN THE YOGA GROUP, INCLUDING AGREATER TREND FOR REDUCED PAIN MEDICATION USAGE. ALTHOUGH SLIGHTLY LESS THAN AT 24 WEEKS, THE YOGA GROUP HAD STATISTICALLY SIGNIFICANT REDUCTIONS IN FUNCTIONAL DISABILITY, PAIN INTENSITY, AND DEPRESSION COMPARED TO STANDARD MEDICAL CARE 6-MONTHS POSTINTERVENTION. CONCLUSION: YOGA IMPROVES FUNCTIONAL DISABILITY, PAIN INTENSITY, AND DEPRESSION IN ADULTS WITH CLBP. THERE WAS ALSO A CLINICALLY IMPORTANT TREND FOR THE YOGA GROUP TO REDUCE THEIR PAIN MEDICATION USAGE COMPARED TO THE CONTROL GROUP. 2009